FBLG – fibrobiologics, inc. (US:NASDAQ)
Stock Stats
News
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
FibroBiologics, Inc. (NASDAQ: FBLG) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Form 10-Q FibroBiologics, Inc. For: Sep 30
Form 8-K FibroBiologics, Inc. For: Oct 25
Form 8-K FibroBiologics, Inc. For: Sep 19
Form 8-K FibroBiologics, Inc. For: Aug 27
Form 4 FibroBiologics, Inc. For: Aug 27 Filed by: Niklas Victoria Ninon Olivia
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.